Linezolid Therapy of Vancomycin-Resistant Enterococcus faecium Experimental Endocarditis

We compared the activities of linezolid (25 mg/kg of body weight, administered intraperitoneally every 8 h) and of vancomycin (25 mg/kg of body weight, administered intraperitoneally every 8 h) in a rat model of vanA vancomycin-resistant Enterococcus faecium experimental endocarditis. Results were e...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Patel, Robin, Rouse, Mark S., Piper, Kerryl E., Steckelberg, James M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90339/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11158767/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.2.621-623.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!